Ads
related to: psa test patient information leaflet- Patient Characteristics
Learn About How Psoriatic Arthritis
Manifests Differently In Patients.
- Risk Of Treatment Delays
Learn How & Why Delay Can Lead To
Further Joint Damage Here.
- Clinical Trial Results
Get Results From A Clinical
Long-term Study Of A Biologic.
- IV Dosing Information
Learn More About IV Dosing &
Administration On The HCP Website.
- PsA Patient Support
Get Patients The Comprehensive
Support They Need With Our Plan.
- Mechanism Of Action
See How This Biologic Selectively
Targets And Blocks IL-17A.
- Patient Characteristics
Search results
Results From The WOW.Com Content Network
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene.PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland in men and the paraurethral glands in women.
Used in conjunction with a PSA test, the PSE test boosts accuracy from 55% to 94% offering a more effective and precise method for detecting and diagnosing prostate cancer. [45] The 4Kscore combines total, free, and intact PSA with human kallikrein 2. [46] It is used to try to determine the risk of a Gleason score greater than 6. [46]
Richard J. Ablin (May 15, 1940 – October 6, 2023) [1] was an American scientist, most notable for research on prostate cancer.According to the Wall Street Journal: . Richard Ablin, a professor of pathology at University of Arizona College of Medicine, discovered the prostate-specific antigen (PSA) in 1970, and for nearly as long, he has argued that it should not be used for routine screening.
For premium support please call: 800-290-4726 more ways to reach us
Prostate cancer is the uncontrolled growth of cells in the prostate, a gland in the male reproductive system below the bladder.Abnormal growth of the prostate tissue is usually detected through screening tests, typically blood tests that check for prostate-specific antigen (PSA) levels.
In the European Union, the European Medicines Agency has jurisdiction and the relevant documents are called the "summary of product characteristics" (SPC or SmPC) and the document for end-users is called the "patient information leaflet" or "package leaflet". The SPC is not intended to give general advice about treatment of a condition but does ...
Ads
related to: psa test patient information leaflet